FRA:KK2
Delisted

Sun A. Kaken . Stock Signals

etoro logo Buy KK2
*Your capital is at risk
3.20€
+0.0200 (+0.629%)
At Close: Apr 18, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Sun A. Kaken Co., Ltd.

General

Signal Type Signal Value Data
Score 0.000 314 days ( 13.98 %
Last Price 3.20€ 0.629 %
Performance History
7 Days
3.42€ 3.20€
-6.43%
30 Days
3.22€ 3.20€
-0.621%
12 Mos
3.64€ 3.20€
-12.09%

10/18

Active Buy Signals

Specific Signals

Short Term
Net score: 40.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low 3.20€ - 3.20€
Trend - 3 mos 2.94 % High Width: 14.33 %
Pred. range - 3 mos 3.21€ - 3.67€ Low 0.259 % - 14.63 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 14, 2023 - 3 days
RSI Short Pivot Signal Buy Very Low Apr 14, 2023 - 3 days
Short MA 3 mos Sell Low Apr 12, 2023 - 5 days
Long MA 3 mos Sell Medium Apr 12, 2023 - 5 days
Short/Long MA 3 mos Sell Medium Mar 29, 2023 - 13 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.35
Signal Type Signal Value Importance Data
Trend - 12 mos -14.07 % Very High Width: 24.80 %
Pred. range - 12 mos 2.38€ - 2.98€ High -25.49 % - -7.02 %
Short MA 12 mos Buy Very High Apr 17, 2023 - 2 days
Long MA 12 mos Buy Very High Mar 31, 2023 - 11 days
Short/Long MA 12 mos Buy Very High Feb 23, 2023 - 37 days
Pivot Long Buy Low Apr 14, 2023 - 3 days
RSI Long Pivot Signal Buy Low Apr 14, 2023 - 3 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SUN A. KAKEN CO., LTD.
Sun A. Kaken .
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE